Jackson Douglas W, Simon Timothy M
Orthopaedic Research Institute and the Southern California Center for Sports Medicine, Long Beach, California 90806, USA.
Microsc Res Tech. 2002 Jul 1;58(1):25-33. doi: 10.1002/jemt.10118.
The specific cells within ligaments and tendons are important to maintain the unique structural and material properties of these tissues. The use of tendon and ligament allografts with living cells for ligament reconstruction would be desirable assuming that these cells would survive after transplantation and continue to function. We assessed the fate of donor cells in fresh allografts of the patellar and anterior cruciate ligaments after transplantation. The cells in these allografts used to reconstruct the anterior cruciate ligament did not survive. This was demonstrated using a DNA probe technique that clearly distinguished donor cells from host cells in the Spanish goat model. The donor cells were replaced by host cells in a rapid manner. The host cells that repopulated the allografts assumed the histologic similarity to the fibroblasts they replace. Simultaneous full-thickness skin transplants in the same animals were not rejected during the interval of rapid loss of donor DNA from the allografts. The absence of rejection of the skin grafts at the one-week interval suggests that no pre-existing antibody associated with an immune reaction was responsible for the rapid loss of DNA in the allografts. The clinical basis for utilizing intra-articular allografts with living donor cells needs further justification to account for their increased expense, more complicated surgical logistics, and higher potential risk of disease transmission.
韧带和肌腱中的特定细胞对于维持这些组织独特的结构和材料特性至关重要。假设这些细胞在移植后能够存活并继续发挥功能,那么使用带有活细胞的肌腱和韧带同种异体移植物进行韧带重建将是理想的。我们评估了移植后新鲜同种异体髌韧带和前交叉韧带移植物中供体细胞的命运。用于重建前交叉韧带的这些同种异体移植物中的细胞未能存活。这在西班牙山羊模型中通过一种能清晰区分供体细胞和宿主细胞的DNA探针技术得到了证实。供体细胞迅速被宿主细胞取代。重新填充同种异体移植物的宿主细胞在组织学上与它们所取代的成纤维细胞相似。在同种异体移植物中供体DNA快速丢失的时间段内,同一动物同时进行的全层皮肤移植未被排斥。一周时间间隔内皮肤移植物未被排斥表明,与免疫反应相关的预先存在的抗体并非导致同种异体移植物中DNA快速丢失的原因。利用带有活体供体细胞的关节内同种异体移植物的临床依据需要进一步论证,以解释其增加的费用、更复杂的手术流程以及更高的疾病传播潜在风险。